Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS)
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.855
https://www.valueinhealthjournal.com/article/S1098-3015(14)02785-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
372
First Page :
A390
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02785-5&doi=10.1016/j.jval.2014.08.855